Come dive into one of the curiously delightful conversations overheard at National Geographic’s headquarters, as we follow explorers, photographers, and scientists to the edges of our big, weird, beautiful world. Hosted by Peter Gwin and Amy Briggs.
…
continue reading
Content provided by Managed Care Cast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Managed Care Cast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Does Chemotherapy Still Have a Role to Play in Cancer Care?
MP3•Episode home
Manage episode 236046039 series 1314490
Content provided by Managed Care Cast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Managed Care Cast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The rate of innovation in oncology has been impressive, with novel therapies, such as chimeric antigen receptor T-cell therapies, and new diagnostics that make it easier to understand which patients will benefit from certain targeted therapies. With all of these innovations coming to market and being tested in clinical trials, it might make sense that some people are ready to move on from the treatments of the past. In a new commentary published in the June issue of The American Journal of Managed Care®, Bruce Feinberg, DO, of Cardinal Health, explains why people shouldn’t count out chemotherapy just yet. In the latest podcast interview, Feinberg explains his views on chemotherapy and how important it still is in cancer care. Reports of the Demise of Chemotherapy Have Been Greatly Exaggerated: www.ajmc.com/journals/issue/2019/2019-vol25-n6/reports-of-the-demise-of-chemotherapy-have-been-greatly-exaggerated Phase 3 TAILORx Results Confirm Chemotherapy Unnecessary in 70% of Women With Early-Stage Breast Cancer: https://www.ajmc.com/conferences/asco-2018/phase-3-tailorx-results-confirm-chemotherapy-unnecessary-in-70-of-women-with-earlystage-breast-cancer TAILORx Results May Mitigate Financial Toxicity: https://www.ajmc.com/contributor/molly-macdonald/2018/06/tailorx-results-may-mitigate-financial-toxicity
…
continue reading
545 episodes
MP3•Episode home
Manage episode 236046039 series 1314490
Content provided by Managed Care Cast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Managed Care Cast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The rate of innovation in oncology has been impressive, with novel therapies, such as chimeric antigen receptor T-cell therapies, and new diagnostics that make it easier to understand which patients will benefit from certain targeted therapies. With all of these innovations coming to market and being tested in clinical trials, it might make sense that some people are ready to move on from the treatments of the past. In a new commentary published in the June issue of The American Journal of Managed Care®, Bruce Feinberg, DO, of Cardinal Health, explains why people shouldn’t count out chemotherapy just yet. In the latest podcast interview, Feinberg explains his views on chemotherapy and how important it still is in cancer care. Reports of the Demise of Chemotherapy Have Been Greatly Exaggerated: www.ajmc.com/journals/issue/2019/2019-vol25-n6/reports-of-the-demise-of-chemotherapy-have-been-greatly-exaggerated Phase 3 TAILORx Results Confirm Chemotherapy Unnecessary in 70% of Women With Early-Stage Breast Cancer: https://www.ajmc.com/conferences/asco-2018/phase-3-tailorx-results-confirm-chemotherapy-unnecessary-in-70-of-women-with-earlystage-breast-cancer TAILORx Results May Mitigate Financial Toxicity: https://www.ajmc.com/contributor/molly-macdonald/2018/06/tailorx-results-may-mitigate-financial-toxicity
…
continue reading
545 episodes
כל הפרקים
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.